Access cutting-edge localized prostate adenocarcinoma treatment through this clinical trial at a research site in Albert Lea. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Albert Lea location
Preparing your pre-screening questions…
Access localized prostate adenocarcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related localized prostate adenocarcinoma treatment provided free
Check if you qualify for this localized prostate adenocarcinoma clinical trial in Albert Lea, MN
No-Cost Study Care
Local to Albert Lea
Convenient for MN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This clinical trial evaluates changes in quality of life after two treatments with near margin-less adaptive radiation therapy (ART) compared to five treatments with standard stereotactic ablative body radiotherapy (SABR) in patients with prostate cancer that has not spread to other parts of the body (localized). ART is a type of radiation therapy that uses information gathered during the treatment cycle to inform, guide, and alter future radiation treatments with respect to location and dose. It may be able to deliver radiation to the site of disease over a shorter time and with smaller margins (less treatment delivered to nearby healthy tissues). SABR is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. Shorter duration near margin-less ART may be just as effective at treating patients with localized prostate cancer but have less quality of life side effects than standard SABR.
Sponsor: Mayo Clinic
Yes, this clinical trial (NCT06325046) has an active research site in Albert Lea, MN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for localized prostate adenocarcinoma treatment options in Albert Lea, MN, this clinical trial (NCT06325046) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Albert Lea research site is actively enrolling participants for this clinical trial. You'll receive care from experienced localized prostate adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all localized prostate adenocarcinoma clinical trials near you to find additional studies recruiting in your area.
See all prostate cancer clinical trials recruiting in Albert Lea — not just this study.
Browse Prostate Cancer Trials in Albert Lea →